BCLYFBarclays PLC
The schedule
- Wed14Oct
Q3 2026 results and outlook for 2027 will be judged against a strong first half and a share price already near the 52-week high, setting a high bar for another clean print and stable UK credit trends.
- Thu10Dec
Into year-end, markets will digest UK and EU banking regulation changes, stress-test outcomes, and global rate expectations under President Trump’s administration, all of which feed into Barclays’ capital requirements, funding costs, and loan-growth outlook.
- Tue9Feb
Full-year 2026 results will reset expectations for 2027, with investors focused on capital returns, UK consumer credit quality, and the sustainability of trading and investment banking revenues.
- Tue23Mar
A scheduled deep-dive on UK consumer and SME credit quality, including cards, mortgages, and unsecured loans, will update the market on arrears trends and provisioning at a late stage in the credit cycle.
- Tue27Apr
Q1 2027 results will show how Barclays is navigating the new rate environment and any turn in UK and US credit costs, setting the tone for 2027 earnings trajectory after a potentially choppy winter for risk assets.
- Tue27Jul
Past
- Tue15Sep
Management lays out progress on the group strategic review, with potential updates on cost cuts, capital release from non-core assets, and scope for higher dividends/buybacks at a time when the shares trade near the 52-week high around $7.00.
- Tue28Jul
Actual outcome: Bull · $7.06 at outcome
Barclays reported Q2 2026 EPS of $0.16, perfectly matching analyst estimates. The stock rallied past the $6.45 bull target, driven by the steady earnings performance and positive developments regarding investment banking fee generation and net interest margin trajectory.
Barclays announces Q2 2026 earnings, featuring metrics on investment banking fee generation and net interest margin trajectory.
